These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6620138)
1. Chemical aspects of propranolol metabolism: 1,1-diethoxy-3-(1-naphthoxy)-2-propanol and related ring-closure products cis- and trans-4-ethoxy-3-hydroxy-3,4-dihydro-2H-naphtho[1,2-b]pyran. Chen CH; Nelson WL J Pharm Sci; 1983 Aug; 72(8):863-5. PubMed ID: 6620138 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and chromatographic separation of the glucuronides of (R)- and (S)-propranolol. Oatis JE; Baker JP; McCarthy JR; Knapp DR J Med Chem; 1983 Dec; 26(12):1687-91. PubMed ID: 6644737 [TBL] [Abstract][Full Text] [Related]
3. Chemical and stereochemical aspects of propranolol metabolism. Diastereomeric 1-(1-hydroxy-2-propylamino)-3-(1-naphthoxy)-2-propanols produced by rat liver microsomal omega-hydroxylation. Shetty HU; Nelson WL J Med Chem; 1986 Oct; 29(10):2004-8. PubMed ID: 3761318 [TBL] [Abstract][Full Text] [Related]
4. [Chemical and pharmaceutical research on pyran derivatives. X. Synthesis of 1-oxo-2-alkyl-3-dialkylamino-1H-naphtho[2,1b]pyrans]. Balbi A; Roma G; Di Braccio M; Ermili A Farmaco Sci; 1978 Nov; 33(11):807-21. PubMed ID: 311298 [TBL] [Abstract][Full Text] [Related]
5. [Chemical and pharmacological research on pyran derivatives. VII. Derivatives of naphto/1',2':5,6/pyran/2,3-c/pyrazole and of 12H-naphto/1',2':5,6/pyran/2,3-d/pyrimidine]. Roma G; Vigevani E; Mazzei M; Ermili A Farmaco Sci; 1977 Jan; 32(1):40-53. PubMed ID: 844604 [TBL] [Abstract][Full Text] [Related]
6. [Chemical and pharmacological research on pyran derivatives. VI. 2-Dialkylamino-4-oxo-4H-naphto/1,2-b/pyrans and derivatives]. Ermili A; Balbi A; Roma G Farmaco Sci; 1976 Sep; 31(9):627-48. PubMed ID: 1010035 [TBL] [Abstract][Full Text] [Related]
7. [Chemical and pharmaceutical research on pyran derivatives. XI. Synthesis of 2-dialkylamino-4-oxo-10-methyl-4H-naphtho[2,3b]pyrans]. Roma G; Vigevani E; Mazzei M; Ermili A; Ambrosini A; Passerini N Farmaco Sci; 1978 Nov; 33(11):822-37. PubMed ID: 744239 [TBL] [Abstract][Full Text] [Related]
8. The structure of propranolol hemisuccinate. Nelson WL; Walker RB Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):435-45. PubMed ID: 734223 [TBL] [Abstract][Full Text] [Related]
9. [Chemical and pharmacological research on derivatives of 1H-naphtho/2,1-b/pyran. V. Behavior of some 1-oxo-3-dialkylamino-1H-naphtho/2,1-b/pyrans substituted in the Mannich reaction]. Ermili A; Mazzei M; Roma G; Ambrosini A; Passerini N Farmaco Sci; 1975 Dec; 30(12):1001-16. PubMed ID: 1204827 [TBL] [Abstract][Full Text] [Related]
10. Chemical aspects of propranolol metabolism. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)propane-1,2-diol as a metabolite of propranolol in the dog, in man and in the rat liver 9000g supernatant fraction. Gupte SM; Bartels MJ; Kerr BM; Laganiere S; Silber BM; Nelson WL Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):235-44. PubMed ID: 6658188 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of the new alpha- and beta-adrenergic antagonist 1-[1-(2-benzodioxanylmethyl)-4-piperidyl]amino-3-(1-naphthoxy)-2- propanol. Mauleón D; Antúnez S; Rosell G Farmaco; 1989 Nov; 44(11):1109-17. PubMed ID: 2577151 [TBL] [Abstract][Full Text] [Related]
12. Attempts to use cyanide ion to trap imine intermediates in the microsomal N-dealkylation of propranolol: formation of alpha-aminonitriles as artifacts when using ether for extraction. Shetty HU; Nelson WL J Pharm Sci; 1985 Sep; 74(9):968-71. PubMed ID: 4067851 [TBL] [Abstract][Full Text] [Related]
13. [Chemical and pharmacological research on derivatives of 1H-naphto/2,1-b/pyran. IV. Substituted 1-oxo-3-dialkylamino-1H-naphto/2,1-b/pyrans]. Ermili A; Mazzei M; Roma G; Cuttica A; Passerini N Farmaco Sci; 1975 Nov; 30(11):870-83. PubMed ID: 1193229 [TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones. Prugh JD; Alberts AW; Deana AA; Gilfillian JL; Huff JW; Smith RL; Wiggins JM J Med Chem; 1990 Feb; 33(2):758-65. PubMed ID: 2299642 [TBL] [Abstract][Full Text] [Related]
15. Regioisomeric products of propranolol metabolism. The monomethyl ethers of 3,4-dihydroxypropranolol and of 3,4-dihydroxypropranolol glycol. Gustavson LM; Nelson WL Drug Metab Dispos; 1988; 16(2):217-21. PubMed ID: 2898336 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3,4-dihydro-2H-pyrans by hetero-Diels-Alder reactions of functionalized alpha,beta-unsaturated carbonyl compounds with N-vinyl-2-oxazolidinone. Pałasz A Org Biomol Chem; 2005 Sep; 3(17):3207-12. PubMed ID: 16106303 [TBL] [Abstract][Full Text] [Related]
17. [Chemical and pharmacological research on derivatives of 1H-naphtho(2,1-b)pyran. I. Synthesis of 1-oxo-3-dialkylamino-1H-naphtho(2,1-b)pyran]. Ermili A; Roma G; Mazzei M; Balbi A; Cuttica A; Passerini N Farmaco Sci; 1974 Mar; 29(3):225-36. PubMed ID: 4827183 [No Abstract] [Full Text] [Related]
18. [Chemical and pharmacological research on derivatives of 1H-naphtho-(2,1-b)pyran. II. Synthesis of 1-oxo-2-dialkylaminomethyl-3-dialkylamino-1H-naphtho(2,1-b)pyran]. Ermili A; Roma G; Mazzei M; Ambrosini A; Passerini N Farmaco Sci; 1974 Mar; 29(3):237-46. PubMed ID: 4827184 [No Abstract] [Full Text] [Related]
19. [Chemistry and pharmacology of pyran derivatives. XVII. Synthesis of 2-(dialkylamino)-5-hydroxychromones and their transformation to derivatives of 2H-pyran[4,3,2-de]-1-benzopyran]. Mazzei M; Ermili A; Balbi A; Di Braccio M; Schiantarelli P; Cadel S Farmaco Sci; 1986 Aug; 41(8):611-21. PubMed ID: 3743752 [TBL] [Abstract][Full Text] [Related]
20. [Chemical and pharmacological research on derivatives of 1H-naphtho(2,1-b)pyran. 3. Synthesis of 2,2'-methylenbis-(1-oxo-3-dialkylamino-1H-naphthol(2,1-b)pyran)]. Ermili A; Roma G; Balbi A Farmaco Sci; 1974 Mar; 29(3):247-55. PubMed ID: 4827185 [No Abstract] [Full Text] [Related] [Next] [New Search]